Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | COVID-19 | Review

Role of rehabilitation amidst the COVID-19 pandemic: a review

Authors: Chaoran Yu, Ernest Johann Helwig

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

COVID-19 remains globally a highly infectious disease targeting multiple organs. Rehabilitation is increasingly valued among the supportive care fields to combat COVID-19 as currently definitive curative treatment remains largely absent. This narrative review is to address rehabilitation related topics associated with the treatment of COVID-19 patients. Nosocomial spread remains a high risk for healthcare workers, with comparable high ratios of exposed workers suffering from the disease with more severe clinical course. Primary principle of rehabilitation is to protect rehabilitation physicians and cover all person-to-person interactions. Translating perspectives are encouraged through each multidisciplinary approach. Rehabilitation for the outpatient remains a potential beneficial approach. Artificial intelligence can potentially provide aid and possible answers to important problems that may emerge involving COVID-19. The real value of rehabilitation in COVID-19 may be very impactful and beneficial for patient’s physical and mental health.
Literature
1.
Wang TJ, Chau B, Lui M, Lam GT, Lin N, Humbert S. Physical Medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769–74.PubMedCrossRef
2.
Janssens JP, Chappuis-Gisin É, Maragkoudakis C, Bhatia C, Da Silva S, Glassey J, Lador F, Soccal PM. Réhabilitation pulmonaire lors de pathologies autres que la BPCO : un programme sur mesure [Pulmonary rehabilitation in respiratory disorders other than COPD : an individualized approach]. Rev Med Suisse. 2018;14(627):2054–7.PubMed
3.
Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation [published correction appears in Am J Respir Crit Care Med. 2014 Jun 15;189(12):1570]. Am J Respir Crit Care Med. 2013;188(8):e13–64.PubMedCrossRef
4.
Chinese Association of Rehabilitation Medicine; Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine; Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(4):308–314.
5.
Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949–59.PubMedCrossRef
6.
Centre for Clinical Practice at NICE (UK). Rehabilitation After Critical Illness. London: National Institute for Health and Clinical Excellence; 2009.
7.
8.
Leopold SS. A conversation with … Natasha Parekh MD, MS-expert on waste and fraud in the US healthcare system. Clin Orthop Relat Res. 2020;478(3):447–50.PubMedPubMedCentralCrossRef
9.
Scherlinger M, Felten R, Gallais F, et al. Refining “Long-COVID” by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection. Infect Dis Ther. 2021;10(3):1747–63.PubMedPubMedCentralCrossRef
10.
Vanichkachorn G, Newcomb R, Cowl CT, et al. Post-COVID-19 Syndrome (Long Haul Syndrome): description of a multidisciplinary clinic at Mayo clinic and characteristics of the initial patient cohort. Mayo Clin Proc. 2021;96(7):1782–91.PubMedCrossRef
11.
12.
Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res. 2020;7(1):11.PubMedPubMedCentral
13.
Lin L, Li TS. Interpretation of Guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV) infection by the National Health Commission (Trial Version 5). Zhonghua Yi Xue Za Zhi. 2020;100:E001.PubMed
14.
Xie SH, Wang Q, Wang LQ, Wang L, Song KP, He CQ. Effect of internet-based rehabilitation programs on improvement of pain and physical function in patients with knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Med Internet Res. 2021;23(1):e21542.PubMedPubMedCentralCrossRef
15.
Thamman R, Janardhanan R. Cardiac rehabilitation using telemedicine: the need for tele cardiac rehabilitation. Rev Cardiovasc Med. 2020;21(4):497–500.PubMedCrossRef
16.
Meinhart F, Stütz T, Sareban M, Kulnik ST, Niebauer J. Mobile technologies to promote physical activity during cardiac rehabilitation: a scoping review. Sensors. 2020;21(1):65.PubMedCentralCrossRef
17.
Yang F, Liu N, Hu JY, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(3):180–2.PubMed
18.
Cullen DL, Rodak B. Clinical utility of measures of breathlessness. Respir Care. 2002;47(9):986–93.PubMed
19.
Banerjee D, Kamuren J, Baird GL, et al. The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension. Pulm Circ. 2017;7(2):384–90.PubMedPubMedCentralCrossRef
20.
Burdon JG, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982;126(5):825–8.PubMed
21.
Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0–10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26(3):216–22.PubMedCrossRef
22.
Cenedese E, Speich R, Dorschner L, et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J. 2006;28(4):808–15.PubMedCrossRef
23.
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.PubMedPubMedCentralCrossRef
24.
Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence. 2014;5(1):20–6.PubMedCrossRef
25.
Garber SL, Krouskop TA. Body build and its relationship to pressure distribution in the seated wheelchair patient. Arch Phys Med Rehabil. 1982;63(1):17–20.PubMed
26.
Gosselink R. Breathing techniques in patients with chronic obstructive pulmonary disease (COPD). Chron Respir Dis. 2004;1(3):163–72.PubMedCrossRef
27.
Kang SW, Bach JR. Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease. Am J Phys Med Rehabil. 2000;79(3):222–7.PubMedCrossRef
28.
29.
Dentice RL, Elkins MR, Dwyer GM, Bye PTP. The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial. BMC Pulm Med. 2018;18(1):3.PubMedPubMedCentralCrossRef
30.
Intensive Care National Audit & Research Centre. ICNARC Report on COVID-19 in Critical Care. Intensive Care National Audit & Research Centre; 2020.
31.
Rychter AM, Zawada A, Ratajczak AE, Dobrowolska A, Krela-Kaźmierczak I. Should patients with obesity be more afraid of COVID-19? Obes Rev. 2020;21(9):e13083.PubMedCrossRef
32.
Gupta R, Misra A. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection with reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). Diabetes Metab Syndr. 2020;14(3):251–4.PubMedPubMedCentralCrossRef
33.
Malavazos AE, Corsi Romanelli MM, Bandera F, Iacobellis G. Targeting the adipose tissue in COVID-19. Obesity. 2020;28(7):1178–9.PubMedCrossRef
34.
35.
36.
Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation [published correction appears in Obesity (Silver Spring). 2020 Oct;28(10):1994]. Obesity. 2020;28(7):1195–9.PubMedCrossRef
37.
Barazzoni R, Bischoff SC, Breda J, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631–8.PubMedPubMedCentralCrossRef
38.
39.
Moreb NA, Albandary A, Jaiswal S, Jaiswal AK. Fruits and vegetables in the management of underlying Conditions for COVID-19 high-risk groups. Foods. 2021;10(2):389.PubMedPubMedCentralCrossRef
40.
“Tracking COVID-19 in California.” Coronavirus COVID-19 Response, 3 Dec. 2020, covid19.ca.gov/state-dashboard/, The state of California.
41.
Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Dittrich S, Domen J, Horn S, Van den Bruel A, Cochrane COVID-19 Diagnostic Test Accuracy Group. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020;7(7):CD013665.PubMed
42.
Sartor Z, Hess B. Increasing the signal-to-noise ratio: COVID-19 clinical synopsis for outpatient providers. J Prim Care Commun Health. 2020;11:2150132720922957.CrossRef
43.
Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 United States, february 12, march 28, 2020. CDC COVID-19 response team.
44.
Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Synd. 2020;14(4):303–10.CrossRef
45.
46.
Kulkarni S, Jenner BL, Wilkinson I. COVID-19 and hypertension. Journal of the renin-angiotensin-aldosterone system. 2020;21(2): 1470320320927851.
47.
Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Polish Arch Intern Med. 2020;130(4):304–9.
48.
Tadic M, Cuspidi C, Mancia G, Dell’Oro R, Grassi G. COVID-19, hypertension and cardiovascular diseases: should we change the therapy? Pharmacol Res. 2020;158:104906.PubMedPubMedCentralCrossRef
49.
Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, Di W, Wang Z, Li Z, Gao H, Liu L, Zhang G. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microb Infect. 2020;9(1):757–60.CrossRef
50.
51.
Yan CH, Faraji F, Prajapati DP, Ostrander BT, DeConde AS. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. 2020;10(7):821–31.PubMedCrossRef
52.
Tanasa IA, Manciuc C, Carauleanu A, Navolan DB, Bohiltea RE, Nemescu D. Anosmia and ageusia associated with coronavirus infection (COVID-19)—what is known? Exp Ther Med. 2020;20(3):2344–7.PubMedPubMedCentral
53.
Risch HA. Early outpatient treatment of symptomatic, high-risk COVID-19 patients that should be ramped up immediately as key to the pandemic crisis. Am J Epidemiol. 2020;189(11):1218–26.PubMedCrossRef
54.
55.
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206.PubMedCrossRef
56.
57.
Alimadadi A, Aryal S, Manandhar I, Munroe PB, Joe B, Cheng X. Artificial intelligence and machine learning to fight COVID-19. Physiol Genomics. 2020;52(4):200–2.PubMedPubMedCentralCrossRef
58.
59.
60.
Hassanien A.E., Salam A., Darwish A.. Artificial intelligence approach to pre- dict the covid-19 patient’s recovery. EasyChair Preprint no. 3223; (EasyChair, 2020a).
61.
Tayarani NMH. Applications of artificial intelligence in battling against Covid-19: a literature review. Chaos Solitons Fractals. 2020;142:110338.CrossRef
62.
Stebbing J, Krishnan V, de Bono S, Ottaviani S, Casalini G, Richardson PJ, Monteil V, Lauschke VM, Mirazimi A, Youhanna S, Tan YJ, Baldanti F, Sarasini A, Terres J, Nickoloff BJ, Higgs RE, Rocha G, Byers NL, Schlichting DE, Nirula A. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020;12(8):e12697.PubMedPubMedCentralCrossRef
63.
64.
Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, El Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF, et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19. New Engl J Med. 2020;384(9):795–807.PubMedCrossRef
65.
Abd-Alrazaq A, Alajlani M, Alhuwail D, Schneider J, Al-Kuwari S, Shah Z, Hamdi M, Househ M. Artificial intelligence in the fight against COVID-19: scoping review. J Med Internet Res. 2020;22(12):e20756.PubMedPubMedCentralCrossRef
66.
Martin-Neuninger R, Ruby MB. What does food retail research tell us about the implications of coronavirus (COVID-19) for grocery purchasing habits? Front Psychol. 2020;11:1448.PubMedPubMedCentralCrossRef
67.
“Alcohol Sales During the COVID-19 Pandemic.” National Institute on Alcohol Abuse and Alcoholism, U.S. Department of Health and Human Services, pubs.niaaa.nih.gov/publications/surveillance-covid-19/COVSALES.htm.
68.
Di Renzo L, Gualtieri P, Pivari F, Soldati L, Attinà A, Cinelli G, Leggeri C, Caparello G, Barrea L, Scerbo F, Esposito E, De Lorenzo A. Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J Transl Med. 2020;18(1):229.PubMedPubMedCentralCrossRef
69.
Tetik KB, Tekinemre IG, Taş S. The effect of the COVID-19 pandemic on smoking cessation success. J Commun Health. 2020;46:1–5.
70.
71.
Fagoonee I, Pellicano R. COVID-19 brings the world economy to its knees. Minerva Med. 2020;111(4):297–9.PubMedCrossRef
72.
Czeisler MÉ, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, Czeisler CA, Howard ME, Rajaratnam S. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–57.PubMedPubMedCentralCrossRef
73.
74.
Wise J. (2020). Covid-19: New coronavirus variant is identified in UK. BMJ (Clinical research ed.), 371, m4857.
Metadata
Title
Role of rehabilitation amidst the COVID-19 pandemic: a review
Authors
Chaoran Yu
Ernest Johann Helwig
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
COVID-19
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-03048-1

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue

Research

Alterations of gut microbiota in gestational diabetes patients during the second trimester of pregnancy in the Shanghai Han population

Research

“Forever young at the table”: metabolic effects of eating speed in obesity

Research

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state

Review

Manifestations of HbSE sickle cell disease: a systematic review

Research

Optimizing the timing of diagnostic testing after positive findings in lung cancer screening: a proof of concept radiomics study

Research

Effects of time-restricted feeding in weight loss, metabolic syndrome and cardiovascular risk in obese women
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits